Slow‐releasing potential of vancomycin‐loaded porous hydroxyapatite blocks implanted into MRSA osteomyelitis
- 1 January 2002
- journal article
- clinical trial
- Published by Wiley in Journal of Biomedical Materials Research
- Vol. 63 (3), 245-251
- https://doi.org/10.1002/jbm.10179
Abstract
Although antibiotic‐loaded hydroxyapatite blocks have been used for the treatment of chronic osteomyelitis, their long‐term potential for releasing antibiotic into human bones is not well known. Five patients with chronic osteomyelitis due to methicillin‐resistant Staphylococcus aureus (MRSA) infection were effectively treated with local implantation of vancomycin‐loaded hydroxyapatite blocks. Blocks were removed during the following reconstructive surgeries when the releasing capability of the blocks, and the bacteriocidal activity of the remaining vancomycin in these blocks could be evaluated. Vancomycin was rapidly released within 1 month after implantation, and by 3 months 90% of vancomycin had leaked from the blocks. At 18 months vancomycin still remained in a bacteriocidal form in the hydroxyapatite blocks, though the blocks had no releasing potential or the eluted vancomycin had been changed to a different form. Vancomycin‐loaded porous hydroxyapatite blocks would be useful for the treatment of chronic osteomyelitis or implant‐associated osteomyelitis due to MRSA.© 2002 Wiley Periodicals, Inc. J Biomed Mater Res (Appl Biomater) 63: 245–251, 2002Keywords
This publication has 14 references indexed in Scilit:
- Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a biodegradable system of lactic acid polymer releasing pefloxacinJournal of Antimicrobial Chemotherapy, 2000
- Activity of linezolid against multi-resistant Gram-positive bacteria from diverse hospitals in the United KingdomJournal of Antimicrobial Chemotherapy, 2000
- Comparative evaluation of daptomycin (LY146032) and vancomycin in the treatment of experimental methicillin-resistant Staphylococcus aureus osteomyelitis in rabbitsAntimicrobial Agents and Chemotherapy, 1989
- The Treatment of Chronic Hematogenous OsteomyelitisPublished by Ovid Technologies (Wolters Kluwer Health) ,1987
- The sustained release of cefotaxim from a fibrin-cefotaxim compound in treatment of osteitisArchives of orthopaedic and trauma surgery, 1986
- Gentamicin-PMMA beads in the treatment of chronic osteomyelitisActa Orthopaedica, 1985
- Antibiotic-loaded Acrylic CementPublished by Ovid Technologies (Wolters Kluwer Health) ,1984
- Vancomycin Therapy in Patients with Impaired Renal Function: A Nomogram for DosageAnnals of Internal Medicine, 1981
- Vancomycin RevisitedAnnals of Internal Medicine, 1978
- Ototoxicity of Neomycin and other AntibioticsThe Journal of Laryngology & Otology, 1962